Bladder dysfunction during the use of tramadol

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue SUPPL. 1, 1999, Pages

  Meyboom, R H B ^a   Brodie Meijer, C C E ^a   Diemont, W L ^a   Van Puijenbroek, E P ^a  

^a Netherlands Pharmacovigilance F ^*  (Netherlands)

Author keywords

Adverse drug reaction; Pharmacovigilance; Tramadol; Urinary retention

Indexed keywords

NARCOTIC ANALGESIC AGENT; TRAMADOL;

ADULT; AGED; BLADDER DYSFUNCTION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MALE; MICTURITION DISORDER; NETHERLANDS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINE RETENTION;

EID: 0032960008     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199904)8:1+3.0.CO;2-M     Document Type: Conference Paper

References (4)

1. Summary of Product Characteristics of Tramal, as approved in the Netherlands. (Repertorium 1998).
2. Drake, M. J., Nixon, P. M. and Crew, J. P. Drug-induced bladder and urinary disorders: incidence, prevention and management. Drug Safety 1998; 19: 45-55.
3. Cossmann, M., Kohnen, C., Langford, R. and McCartney, C. Tolérance et sécurité d'emploi du tramdadol. Drugs 1997; 53(Suppl. 2): 50-62.
4. Dukes, M. N. G. (Ed.) Meyler's Side Effects of Drugs, 13th edn., Elsevier Science, Amsterdam, 1996.